Daniel Billen, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 4,650 shares at $11.26 ($52K) on 2023-05-23, disclosed to the SEC on 2023-05-23.
Open-market sale of $52k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.